Abivax (AAVXF) Exchange Rate Effect (2024 - 2026)
Abivax (AAVXF) posted Exchange Rate Effect of $8.7 million for Q1 2026, up 100.07% on a QoQ basis from -$11.9 billion in Q4 2025, and up 1278.98% year-over-year from $629527.5 in Q1 2025.
Analysis
Abivax (AAVXF) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Abivax has reported Exchange Rate Effect for 3 years, with the latest figure at $8.7 million in Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 1278.98% year-over-year to $8.7 million in Q1 2026; TTM through Mar 2026 was -$11.9 billion, a 568.01% decrease from a year earlier, with the FY2025 full-year figure at -$11.9 billion, down 568.79% from the prior year.
- Exchange Rate Effect was $8.7 million for Q1 2026 at Abivax, up from -$11.9 billion in the prior quarter.
- The five-year high for Exchange Rate Effect was $2.5 billion in Q4 2024, with the low at -$11.9 billion in Q4 2025.
- Average Exchange Rate Effect over 3 years is -$1.0 billion, with a median of $485676.3 recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect tumbled 568.35% in 2025, then soared 1278.98% in 2026.
- Over 3 years, Exchange Rate Effect stood at $2.5 billion in 2024, then sank by 568.35% to -$11.9 billion in 2025, then soared by 100.07% to $8.7 million in 2026.
- The last three Exchange Rate Effect figures came in at $8.7 million (Q1 2026), -$11.9 billion (Q4 2025), and $12.5 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.51 Bn | 197.52 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.48 Bn | 178.30 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.45 Bn | 124.60 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.72 Bn | 49.59 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 30.31 Bn | 30.31 Bn | 1.16 Mn | 315,000.00 |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | 8.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 8.68 Mn |
| Dec 31, 2025 | -11.92 Bn |
| Sep 30, 2025 | 12.47 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | -736,319.11 |
| Dec 31, 2024 | 2.55 Bn |
| Sep 30, 2024 | -2.13 Mn |
| Jun 30, 2024 | 485,676.30 |
| Mar 31, 2024 | 1.43 Mn |